Tag:
Memorial Sloan-Kettering Cancer Center
Latest Headlines
Latest Headlines
Medical groups revise lung cancer CT screening guidelines
Amid debate over the merits of annual CT scans to look for lung cancer in smokers, three medical groups are recommending them for one particular group: current or former heavy smokers aged 55 to 74.
Memorial Sloan-Kettering, IBM partner on latest Watson technology project
Memorial Sloan-Kettering Cancer Center (MSKCC) and IBM have agreed to work together to develop a clinical decision support tool using IBM Watson technology to help create individualized cancer
Hospitals take note of food offerings: Gourmet or gross?
While some hospitals are taking note of their menus (and their patients' waistlines), many others still lag behind in the nutrition department. A recent study by the Physicians Committee for
UPenn sues Sloan-Kettering president for $1B over alleged stolen research
The President of Memorial Sloan-Kettering Cancer Center is facing a more than $1 billion lawsuit from the cancer center at the University of Pennsylvania--his former employer--over what the latter
Study: Robots more expensive, not more effective for surgery
Although surgical robots are a must-have for many hospitals and health systems looking to keep pace with their competitors , such technology isn't necessarily any more effective than regular surgery,
Patricia Skarulis - Disruptive Forces in Health IT
Who: Patricia Skarulis Current position: Vice President and Chief Information Officer, Memorial Sloan-Kettering Cancer Center Location: New York Fast Facts: Before being named vice president and CIO
Unconventional treatments more common with cancer patients
Despite a growing trend among cancer patients to look for "natural" alternatives to traditional treatments, many doctors warn that such decisions could jeopardize any chance at all of beating the
Stanford limiting drugmaker CME financing
Today, Stanford University is expected to announce that it will set strict limits on pharmaceutical industry financing of continuing education for doctors at its medical school. This marks a major
Case study: NY hospital drops pharma CME funding
Think you can't afford to drop pharmaceutical company funding for continuing medical education? Perhaps executives at Memorial Sloan-Kettering Cancer Center had the same fears, but if so, they got
